THERMOGENESIS HOLDINGS, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.62 USD | +5.64% |
|
-8.15% | +3.16% |
Presentation Operator MessageOperator (Operator)Good day. And welcome to the 2020 ThermoGenesi...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
ThermoGenesis Holdings, Inc. develops and commercializes a range of automated technologies for cell-banking, cell-processing, and cell-based therapeutics. The Company provides the AutoXpress and BioArchive platforms for automated clinical bio-banking, the PXP platform for point-of-care cell-based therapies and X-Series products for cell processing services. Its product lines include Clinical Bio-Banking Applications, Point-of-Care Applications and Cell Processing. Its Clinical Bio-Banking Applications include AXP II Automated Cell Separation System and BioArchive Automated Cryopreservation System. Its Point-of-Care Applications include PXP Point-of-Care System, and PXP-1000 System. Its Cell Processing includes X-Series Products for general laboratory use: X-Lab for cell isolation, X-Wash System for cell washing and reformulation, and X-Mini for high efficiency small scale cell purification. The Company markets and sells its medical device products through independent distributors.
Sector
Office Equipment
Calendar
2024-08-13
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.5869
USD
Average target price
5
USD
Spread / Average Target
+751.93%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +3.16% | 4.67M | |
| +10.35% | 8.27B | |
| -4.89% | 2.98B | |
| +6.45% | 2.15B | |
| -28.04% | 1.1B | |
| +13.41% | 1.05B | |
| -3.29% | 865M | |
| -23.22% | 759M | |
| -53.81% | 708M | |
| -23.31% | 688M |
- Stock Market
- Equities
- THMO Stock
- News ThermoGenesis Holdings, Inc.
- Transcript : ThermoGenesis Holdings, Inc. - Shareholder/Analyst Call
